The Triple Negative Breast Cancer Foundation
Encyclopedia
The Triple Negative Breast Cancer Foundation ("TNBC Foundation" or "TNBC") is a nonprofit organization dedicated to raising awareness
of triple-negative breast cancer. The foundation supports scientists and researchers
in their efforts to determine the definitive causes of triple-negative breast cancer
so that effective detection, diagnosis, prevention, and treatment can be pursued and achieved.
Since its inception in 2006, TNBC has raised over $2 million to further this mission.
convened one of the first "think tank
s" dedicated specifically to triple-negative breast cancer. The meeting was held prior to the opening of the annual San Antonio Breast Cancer Symposium.
Thirty researchers, from leading cancer institutions in North America and Europe, were invited to share information on the latest science, to discuss potential research collaborations and develop a scientific agenda for future research and clinical trials to find effective treatment for women with this subtype of breast cancer. The meeting also marked the first joint effort between TNBC and Susan G. Komen for the Cure to share resources to accelerate research and progress for women who are not benefiting from recent advances in breast cancer research.
TNBC has convened the Symposium each year since 2007. In 2010, over 30 researchers and scientists attended the Symposium, which was again co-sponsored by Susan G. Komen for the Cure and The Breast Cancer Research Foundation (BCRF). That year, the Triple Negative Breast Cancer Foundation awarded its first independent grants to two researchers who were doing research in the area of triple-negative breast cancer.
for triple-negative breast cancer.
Breast cancer awareness
Breast cancer awareness is an effort to raise awareness of breast cancer and reduce the disease's stigma by educating people about its symptoms and treatment options...
of triple-negative breast cancer. The foundation supports scientists and researchers
Cancer research
Cancer research is basic research into cancer in order to identify causes and develop strategies for prevention, diagnosis, treatments and cure....
in their efforts to determine the definitive causes of triple-negative breast cancer
Breast cancer
Breast cancer is cancer originating from breast tissue, most commonly from the inner lining of milk ducts or the lobules that supply the ducts with milk. Cancers originating from ducts are known as ductal carcinomas; those originating from lobules are known as lobular carcinomas...
so that effective detection, diagnosis, prevention, and treatment can be pursued and achieved.
Since its inception in 2006, TNBC has raised over $2 million to further this mission.
History
TNBC Foundation was founded in 2006 in honor of Nancy Block-Zenna, who, at age 35, was diagnosed with triple-negative breast cancer. In response to her diagnosis, her close friends launched the TNBC Foundation to raise awareness and support research for this particular type of breast cancer. Block-Zenna died of the disease in 2007, 2 years after her diagnosis.Symposium
On December 11, 2007, the TNBC Foundation and Susan G. Komen for the CureSusan G. Komen for the Cure
Susan G. Komen for the Cure, formerly known as The Susan G. Komen Breast Cancer Foundation, often referred to as simply Komen, is the most widely known, largest and best-funded breast cancer organization in the US....
convened one of the first "think tank
Think tank
A think tank is an organization that conducts research and engages in advocacy in areas such as social policy, political strategy, economics, military, and technology issues. Most think tanks are non-profit organizations, which some countries such as the United States and Canada provide with tax...
s" dedicated specifically to triple-negative breast cancer. The meeting was held prior to the opening of the annual San Antonio Breast Cancer Symposium.
Thirty researchers, from leading cancer institutions in North America and Europe, were invited to share information on the latest science, to discuss potential research collaborations and develop a scientific agenda for future research and clinical trials to find effective treatment for women with this subtype of breast cancer. The meeting also marked the first joint effort between TNBC and Susan G. Komen for the Cure to share resources to accelerate research and progress for women who are not benefiting from recent advances in breast cancer research.
TNBC has convened the Symposium each year since 2007. In 2010, over 30 researchers and scientists attended the Symposium, which was again co-sponsored by Susan G. Komen for the Cure and The Breast Cancer Research Foundation (BCRF). That year, the Triple Negative Breast Cancer Foundation awarded its first independent grants to two researchers who were doing research in the area of triple-negative breast cancer.
Grant initiatives
In 2008, the Triple Negative Breast Cancer Foundation co-funded a research grant with the Susan G. Komen for the Cure Foundation. TNBCF's initial $500,000 contribution marks the first time a nonprofit partner has co-funded one of Komen's "Promise Grants". Worth $7.5 million over five years, Promise Grants are designed to bring clinical researchers and basic scientists together to deliver new treatments for patients as quickly as possible. The Promise Grant was awarded to Dr. Andreas Forero of the University of Alabama, Birmingham Comprehensive cancer Center. Forero and his team are researching a new targeted therapyTargeted therapy
Targeted therapy is a type of medication that blocks the growth of cancer cells by interfering with specific targeted molecules needed for carcinogenesis and tumor growth, rather than by simply interfering with rapidly dividing cells...
for triple-negative breast cancer.